Healthcare & Life Sciences
Precirix NV
Belgium
series-b
series-b
Stage
1
Investors
About
Precirix NV develops immunotherapy and protein engineering solutions aimed at enhancing the efficacy of antibody-based treatments for cancer and autoimmune diseases.
Explore Precirix NV's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.